Home >> Research Area >> Xylometazoline HCl

Xylometazoline HCl

CAS# 1218-35-5

Xylometazoline HCl

Catalog No. BCC4879----Order now to get a substantial discount!

Product Name & Size Price Stock
Xylometazoline HCl: 5mg $6 In Stock
Xylometazoline HCl: 10mg Please Inquire In Stock
Xylometazoline HCl: 20mg Please Inquire Please Inquire
Xylometazoline HCl: 50mg Please Inquire Please Inquire
Xylometazoline HCl: 100mg Please Inquire Please Inquire
Xylometazoline HCl: 200mg Please Inquire Please Inquire
Xylometazoline HCl: 500mg Please Inquire Please Inquire
Xylometazoline HCl: 1000mg Please Inquire Please Inquire
Related Products
  • XMD17-109

    Catalog No.:BCC2061
    CAS No.:1435488-37-1
  • FR 180204

    Catalog No.:BCC3669
    CAS No.:865362-74-9
  • VRT752271

    Catalog No.:BCC4122
    CAS No.:869886-67-9
  • VX-11e

    Catalog No.:BCC2051
    CAS No.:896720-20-0

Quality Control of Xylometazoline HCl

Number of papers citing our products

Chemical structure

Xylometazoline HCl

3D structure

Chemical Properties of Xylometazoline HCl

Cas No. 1218-35-5 SDF Download SDF
PubChem ID 5282386 Appearance Powder
Formula C16H25ClN2 M.Wt 280.84
Type of Compound N/A Storage Desiccate at -20°C
Solubility H2O : 50 mg/mL (178.04 mM; Need ultrasonic)
DMSO : 25 mg/mL (89.02 mM; Need ultrasonic)
Chemical Name 2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole;hydrochloride
SMILES [H+].[Cl-].Cc1cc(cc(C)c1CC2=NCCN2)C(C)(C)C
Standard InChIKey YGWFCQYETHJKNX-UHFFFAOYSA-N
Standard InChI InChI=1S/C16H24N2.ClH/c1-11-8-13(16(3,4)5)9-12(2)14(11)10-15-17-6-7-18-15;/h8-9H,6-7,10H2,1-5H3,(H,17,18);1H
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Xylometazoline HCl Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Xylometazoline HCl Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Xylometazoline HCl

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 3.5607 mL 17.8037 mL 35.6075 mL 71.2149 mL 89.0187 mL
5 mM 0.7121 mL 3.5607 mL 7.1215 mL 14.243 mL 17.8037 mL
10 mM 0.3561 mL 1.7804 mL 3.5607 mL 7.1215 mL 8.9019 mL
50 mM 0.0712 mL 0.3561 mL 0.7121 mL 1.4243 mL 1.7804 mL
100 mM 0.0356 mL 0.178 mL 0.3561 mL 0.7121 mL 0.8902 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on Xylometazoline HCl

Xylometazoline is an α-adrenoceptor agonist commonly used as nasal decongestant, exhibits highest potency at α2B-adrenoceptor subtype with EC50 of 99 μM. Phase 4.

Featured Products
New Products
 

References on Xylometazoline HCl

Topical glucocorticoid reduces the topical decongestant-induced histologic changes in an animal model nasal mucosa.[Pubmed:22374848]

Laryngoscope. 2012 Apr;122(4):741-6.

OBJECTIVES/HYPOTHESIS: To investigate the histologic consequences of simultaneous nasal glucocorticosteroid and Xylometazoline HCl administration in the rabbit nasal mucosa. STUDY DESIGN: Prospective randomized study. METHODS: Twenty New Zealand male rabbits were randomly placed into three groups: group I, control (n = 6); group II, Xylometazoline HCl (n = 8); or group III, Xylometazoline HCl-fluticasone furoate (n = 6). Group I received no treatment. Groups II and III received two intranasal puffs of Xylometazoline HCl 0.5 mg/mL twice daily or two puffs of Xylometazoline HCl 0.5 mg/mL twice daily plus one puff of 27.5 mug fluticasone furoate twice daily to each nostril (110 mug), respectively. At the end of 3 weeks, the rabbits were sacrificed. The mucosa of the nasal cavities was excised. Specimen sections (5 mum) were stained with hematoxylin and eosin, mucicarmine, and Gomori one-step trichrome and were examined under a light microscope. The presence of edema, congestion, inflammatory cell infiltration, nasociliary loss, epithelial and nerve-ending degeneration, and goblet cell increase were evaluated semiquantitatively (grades 0-3). RESULTS: Statistically significant differences were detected between groups II and III in terms of edema, congestion, inflammatory cell infiltration, nasociliary loss, and epithelial degeneration (P = .006, P = .049, P = .015, P = .014, and P = .049, respectively). Nerve-ending degeneration, goblet cell increase, and quantitative goblet and neutrophil cell counts did not yield statistically significant differences between groups II and III (P = .137, P = .580, P = .770, and P = .616, respectively). CONCLUSIONS: The combined simultaneous intranasal administration of Xylometazoline HCl and fluticasone furoate appears to be beneficial in minimizing the long-term usage-associated congestion, edema, inflammatory cell infiltration, epithelial degeneration, and nasociliary loss in the rabbit model nasal mucosa.

Correlation between the sensitivity of the ciliary beat frequency of human adenoid tissue and chicken embryo tracheas for some drugs.[Pubmed:6180466]

Rhinology. 1982 Jun;20(2):81-7.

The effects of benzalkonium chloride, chlorbutol,xylometazoline and naphazoline on the ciliary beat frequency of human adenoids and chicken embryo tracheas have been determined and compared. Chlorbutol 0.5% appeared to arrest ciliary motion in both tissues within 5 minutes. Rinsing with Locke Ringer solution (LR) restored the ciliary motion almost completely in both cases. Benzalkonium chloride 0.006% +EDTA 0.1% decreased the ciliary beat frequency 35% for the human tissues and 50% for the chicken tissues after a contact of 20 minutes. In both cases the frequency hardly changed after rinsing with LR. Naphazoline nitrate 0.1% and Xylometazoline HCl 0.05% have reversible effects on the ciliary beat frequency of both human adenoids and chicken embryo tracheas. Cilia of human adenoids appeared to be more sensitive for xylometazoline than for naphazoline; whereas cilia of chicken embryo tracheas were more affected by naphazoline than by xylometazoline. The results with human adenoids and chicken embryo tracheas show a correlation (correlation coeff. = 0.82, p less than 0.005). In the initial response the differences in sensitivity to preservatives and drugs were in many cases statistically significant, but the final effects were similar.

Description

Xylometazoline hydrochloride is an α-adrenoceptor agonist commonly used as nasal decongestant.

Keywords:

Xylometazoline HCl,1218-35-5,Natural Products, buy Xylometazoline HCl , Xylometazoline HCl supplier , purchase Xylometazoline HCl , Xylometazoline HCl cost , Xylometazoline HCl manufacturer , order Xylometazoline HCl , high purity Xylometazoline HCl

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: